Extended Data Fig. 5: mTOG expression is independent from recurrent mutations and cytogenetic abnormalities in MDS.

Mutational landscape of the MDS patient cohort (n=50) used for this study. Patients are stratified based on mTOG levels from low to high. mTOG levels were independent from recurrent MDS genetic abnormalities (Mann-Whitney U test).